Pfizer

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE182A01018
  • NSEID: PFIZER
  • BSEID: 500680
INR
4,585.00
61.6 (1.36%)
BSENSE

Feb 02

BSE+NSE Vol: 9.77 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Acutaas Chemical
Emcure Pharma
J B Chemicals &
Neuland Labs.
Sai Life
Gland Pharma
Astrazeneca Phar
ERIS Lifescience
Pfizer
Wockhardt
Piramal Pharma

Why is Pfizer Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of 2.01% and Operating profit at 7.55% over the last 5 years
2
With ROE of 18.3, it has a Very Expensive valuation with a 5.4 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 0.99%, its profits have risen by 15.2% ; the PEG ratio of the company is 1.9
  • At the current price, the company has a high dividend yield of 3.7
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Pfizer for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Pfizer
0.99%
0.04
24.83%
Sensex
5.37%
0.47
11.36%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
2.01%
EBIT Growth (5y)
7.55%
EBIT to Interest (avg)
56.82
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.69
Sales to Capital Employed (avg)
0.74
Tax Ratio
24.60%
Dividend Payout Ratio
119.20%
Pledged Shares
0
Institutional Holding
19.76%
ROCE (avg)
49.32%
ROE (avg)
18.68%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
29
Industry P/E
32
Price to Book Value
5.37
EV to EBIT
23.91
EV to EBITDA
22.15
EV to Capital Employed
15.17
EV to Sales
7.59
PEG Ratio
1.93
Dividend Yield
3.65%
ROCE (Latest)
63.46%
ROE (Latest)
18.32%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
OPERATING CF(Y)

Highest at Rs 659.75 Cr

PAT(Latest six months)

At Rs 380.77 cr has Grown at 23.20%

ROCE(HY)

Highest at 24.41%

DPS(Y)

Highest at Rs 165.00

DPR(Y)

Highest at 119.20%

NET SALES(Q)

Highest at Rs 642.34 cr

PBDIT(Q)

Highest at Rs 229.93 cr.

PBT LESS OI(Q)

Highest at Rs 213.52 cr.

-3What is not working for the Company
INVENTORY TURNOVER RATIO(HY)

Lowest at 4.75 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 9.74 times

Loading Valuation Snapshot...

Here's what is working for Pfizer

Profit After Tax (PAT) - Latest six months
At Rs 380.77 cr has Grown at 23.20%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Operating Cash Flow - Annually
Highest at Rs 659.75 Cr
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Net Sales - Quarterly
Highest at Rs 642.34 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 229.93 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 213.52 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 213.52 cr has Grown at 21.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 175.65 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Dividend per Share (DPS) - Annually
Highest at Rs 165.00
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (Rs)

Dividend Payout Ratio (DPR) - Annually
Highest at 119.20%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Here's what is not working for Pfizer

Inventory Turnover Ratio- Half Yearly
Lowest at 4.75 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio- Half Yearly
Lowest at 9.74 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio